|
INO80 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73450143137188E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.06420444573519E-11 |
| Normal-vs-Stage2 |
3.25479999951916E-07 |
| Normal-vs-Stage3 |
2.13240536339754E-11 |
| Normal-vs-Stage4 |
4.05230293765158E-11 |
| Stage1-vs-Stage2 |
7.487000E-01 |
| Stage1-vs-Stage3 |
2.810400E-01 |
| Stage1-vs-Stage4 |
8.066100E-02 |
| Stage2-vs-Stage3 |
6.727800E-01 |
| Stage2-vs-Stage4 |
3.688800E-01 |
| Stage3-vs-Stage4 |
5.304400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25930385511219E-13 |
| Normal-vs-AfricanAmerican |
5.775400E-04 |
| Normal-vs-Asian |
3.39720000019916E-07 |
| Caucasian-vs-AfricanAmerican |
2.162400E-01 |
| Caucasian-vs-Asian |
6.002000E-01 |
| AfricanAmerican-vs-Asian |
4.531400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.74322836352803E-12 |
| Normal-vs-Female |
3.17512682812549E-12 |
| Male-vs-Female |
4.853400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.37120039953732E-10 |
| Normal-vs-Age(41-60Yrs) |
1.1369016839069E-11 |
| Normal-vs-Age(61-80Yrs) |
1.19689813615764E-11 |
| Normal-vs-Age(81-100Yrs) |
4.351200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.923200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.449800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.552000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.481200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.848800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.280400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.746600E-01 |
| Classical-VS-Follicular |
1.750060E-02 |
| Classical-VS-Other |
1.351840E-01 |
| Classical-VS-Normal |
2.78780332152451E-11 |
| Tall-VS-Follicular |
4.668000E-01 |
| Tall-VS-Other |
3.616400E-01 |
| Tall-VS-Normal |
3.6724999996629E-07 |
| Follicular-VS-Other |
6.877000E-01 |
| Follicular-VS-Normal |
5.37199951189393E-10 |
| Other-VS-Normal |
4.599600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14569465026193E-11 |
| Normal-vs-N1 |
9.55080459164037E-11 |
| N0-vs-N1 |
1.822640E-01 |
|
|
